Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark A. Goldsmith currently holds 276,698 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Goldsmith has been a net seller of RVMD stock. They have purchased $0 and sold $30.7M worth of shares.
Mark A. Goldsmith's most recent insider trade was on Mar 17, 2026, when they sold 12,871 shares at $99.48 per share.
Mark A. Goldsmith serves as Executive at Revolution Medicines, Inc. (RVMD). They have executed 164 insider transactions totaling $30.7M over their tenure at the company.
Mark A. Goldsmith holds the position of Executive at Revolution Medicines, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Mark A. Goldsmith has shown a selling trading pattern, with $0 in total purchases and $30.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark A. Goldsmith was on Nov 25, 2025, when they sold $4.5M worth of RVMD shares. This transaction involved 60,000 shares at $75.08 per share.
Mark A. Goldsmith currently owns 276,698 shares of Revolution Medicines, Inc. (RVMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark A. Goldsmith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark A. Goldsmith has 164 Form 4 filings on record as an insider at Revolution Medicines, Inc..
Set alerts for Mark A. Goldsmith and 40,000+ other insiders.